logo-loader
viewSkinBioTherapeutics PLC

SkinBioTherapeutics boosts fundraise by £450,000 through open offer

Acceptances for the offer, which was priced at 16p, amounted to 2.8mln shares

SkinBioTherapeutics PLC -
Croda is one of SkinBioTherapeutics' partners

SkinBioTherapeutics PLC (LON:SBTX) said it has received an additional £450,000 from an open offer that accompanied a £4mln placing  two weeks ago.

Acceptances for the offer, which was priced at 16p, amounted to 2.8mln shares said the microbiome specialist.

In total, its means the AIM-listed group has raised £4.45mln, which will be used to expand its product pipeline from skin into haircare, oral and acne.

SkinBioTherapeutics also wants to develop own-label product lines and establish its own in-house scientific capability and related infrastructure.

Quick facts: SkinBioTherapeutics PLC

Price: 29 GBX

AIM:SBTX
Market: AIM
Market Cap: £45.21 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of SkinBioTherapeutics PLC named herein, including the promotion by the Company of SkinBioTherapeutics PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Skinbiotherapeutics get set for live data trial to target skin conditions...

SkinBioTherapeutics PLC's (LON:SBTX) Stuart Ashman talks to Proactive London about their wholly-owned subsidiary AxisBiotix Limited which is getting ready for their food supplement consumer study. The study, which will accept around 200 applicants, the participants will be asked to take a...

1 day, 5 hours ago

2 min read